The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy-Reference-Cited by-同舟云学术

The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy

Published:2021-05 Issue: Volume:137 Page:111364
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Asadzadeh Zahra,Mansoori Behzad,Mohammadi Ali,Kazemi Tohid,Mokhtarzadeh Ahad,Shanehbandi Dariush,Hemmat Nima,Derakhshani Afshin,Brunetti Oronzo,Safaei Sahar,Aghajani Marjan,Najafi Souzan,Silvestris Nicola,Baradaran Behzad

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference26 articles.

1. Colorectal cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. Worldwide burden of colorectal cancer: a review;Favoriti;Updates Surg.,2016

3. Potential mechanisms of CD133 in cancer stem cells;Jang;Life Sci.,2017

4. RNAi therapies: drugging the undruggable;Wu;Sci. Transl. Med.,2014

5. RNA interference and its role in cancer therapy;Mansoori;Adv. Pharm. Bull.,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel strategies in HPV‑16‑related cervical cancer treatment: An in vitro study of combined siRNA-E5 with oxaliplatin and ifosfamide chemotherapy;Gene;2025-01

2. Ribosomal Protein L9 Maintains Stemness of Colorectal Cancer via an ID-1 Dependent Mechanism;Journal of Cancer Prevention;2024-06-30

3. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways;International Journal of Molecular Sciences;2024-04-07

4. CD133 significance in glioblastoma development: in silico and in vitro study;European Journal of Medical Research;2024-03-06

5. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons;International Journal of Molecular Sciences;2023-12-12